Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer
AIM: To investigate the expression of integrin αvβ6 and matrix metalloproteinase 9(MMP-9), their association with prognostic factors and to assess their predictive role in gastric cancer patients.METHODS: Immunohistochemistry was used to determine the expressions of integrin αvβ6 and MMP-9 in 126 sp...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2016-04, Vol.22 (14), p.3852-3859 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3859 |
---|---|
container_issue | 14 |
container_start_page | 3852 |
container_title | World journal of gastroenterology : WJG |
container_volume | 22 |
creator | Lian, Pei-Long Liu, Zhao Yang, Guang-Yun Zhao, Rui Zhang, Zhao-Yang Chen, Yue-Guang Zhuang, Zhuo-Nan Xu, Ke-Sen |
description | AIM: To investigate the expression of integrin αvβ6 and matrix metalloproteinase 9(MMP-9), their association with prognostic factors and to assess their predictive role in gastric cancer patients.METHODS: Immunohistochemistry was used to determine the expressions of integrin αvβ6 and MMP-9 in 126 specimens from patients with primary gastric carcinoma. Associations between immunohistochemical staining and various clinic pathologic variables of tissue specimens were evaluated by the χ2 test and Fisher’s exact test. Expression correlation of αvβ6 and MMP-9 was assessed using bivariate correlation analysis. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 56 mo(ranging from 2 mo to 94 mo).Four different combinations of αvβ6 and MMP-9 levels(that is, both markers positive, both markers negative, αvβ6 positive with MMP-9 negative, and αvβ6 negative with MMP-9 positive) were evaluated for their relative effect on survival. The difference in survival curves was evaluated with a log-rank test. Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis.RESULTS: The expressions of integrin αvβ6 and MMP-9 were investigated in 126 cases, among which 34.92% were positive for αvβ6 expression, and 42.06% for MMP-9 expression. The expression of αvβ6 was associated with Lauren type, differentiation, N stage, and TNM stage(the P values were 0.006, 0.038, 0.016, and 0.002, respectively). While MMP-9 expression was associated with differentiation, T stage, N stage, and TNM stage(the P values were 0.039, 0.014, 0.033, and 0.008, respectively). The positive correlation between αvβ6 and MMP-9 in gastric cancer was confirmed by a correlation analysis. The Kaplan-Meier survival analysis showed that patients with expression of αvβ6 or MMP-9 alone died earlier than those with negative expression and that patients who were both αvβ6 and MMP-9 positive had a shorter overall survival than those with the opposite pattern(both αvβ6 and MMP-9 negative)(P = 0.000). A Cox model indicated that positive expression of αvβ6 and MMP-9, diffuse Lauren type, as well as a senior grade of N stage, M stage, and TNM stage were predictors of a poor prognosis in univariate analysis. Only αvβ6 and MMP-9 retained their significance when adjustments were made for other known prognostic factors in multivariate analysis(RR = 2.632, P = 0.003 and RR = 1.813, P = 0.007).CONCLUSION: The |
doi_str_mv | 10.3748/wjg.v22.i14.3852 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4814749</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849544952484955</cqvip_id><sourcerecordid>1781537635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2852-1b018c4057bbc5f3223079e5fd2d21eef18f70ff6dea810ccadd68f4d5a3c5ee3</originalsourceid><addsrcrecordid>eNpVkU9rFDEYh4Modq3ePUmOXmbN30nmIkixWih4UfAWspk3sykzyTaZnerHsh-kn8msXRcNhATy-z154UHoNSVrroR-d3czrBfG1oGKNdeSPUErxmjXMC3IU7SihKim40ydoRel3BDCOJfsOTpjiqhWKbpC36_iDEMOET_8Wh7uW2xjjyc75_ADTzDbcUy7nGYI0RbAHXYpZxjtDPguzFtc9nkJix1xBQy21JrDzkYH-SV65u1Y4NXxPEffLj9-vfjcXH_5dHXx4bpxrA7c0A2h2gki1WbjpOeMcaI6kL5nPaMAnmqviPdtD1ZT4pzt-1Z70UvLnQTg5-j9I3e330zQO4hztqPZ5TDZ_NMkG8z_LzFszZAWIzQVSnQV8PYIyOl2D2U2UygOxtFGSPtiqNJUctVyWaPkMepyKiWDP31DiTkIMVWIqUJMFWIOQmrlzb_jnQp_DdQAPzK3KQ63IQ6nTEf0YXWSCC06Kepmf26S_wYyKJuL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781537635</pqid></control><display><type>article</type><title>Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lian, Pei-Long ; Liu, Zhao ; Yang, Guang-Yun ; Zhao, Rui ; Zhang, Zhao-Yang ; Chen, Yue-Guang ; Zhuang, Zhuo-Nan ; Xu, Ke-Sen</creator><creatorcontrib>Lian, Pei-Long ; Liu, Zhao ; Yang, Guang-Yun ; Zhao, Rui ; Zhang, Zhao-Yang ; Chen, Yue-Guang ; Zhuang, Zhuo-Nan ; Xu, Ke-Sen</creatorcontrib><description>AIM: To investigate the expression of integrin αvβ6 and matrix metalloproteinase 9(MMP-9), their association with prognostic factors and to assess their predictive role in gastric cancer patients.METHODS: Immunohistochemistry was used to determine the expressions of integrin αvβ6 and MMP-9 in 126 specimens from patients with primary gastric carcinoma. Associations between immunohistochemical staining and various clinic pathologic variables of tissue specimens were evaluated by the χ2 test and Fisher’s exact test. Expression correlation of αvβ6 and MMP-9 was assessed using bivariate correlation analysis. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 56 mo(ranging from 2 mo to 94 mo).Four different combinations of αvβ6 and MMP-9 levels(that is, both markers positive, both markers negative, αvβ6 positive with MMP-9 negative, and αvβ6 negative with MMP-9 positive) were evaluated for their relative effect on survival. The difference in survival curves was evaluated with a log-rank test. Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis.RESULTS: The expressions of integrin αvβ6 and MMP-9 were investigated in 126 cases, among which 34.92% were positive for αvβ6 expression, and 42.06% for MMP-9 expression. The expression of αvβ6 was associated with Lauren type, differentiation, N stage, and TNM stage(the P values were 0.006, 0.038, 0.016, and 0.002, respectively). While MMP-9 expression was associated with differentiation, T stage, N stage, and TNM stage(the P values were 0.039, 0.014, 0.033, and 0.008, respectively). The positive correlation between αvβ6 and MMP-9 in gastric cancer was confirmed by a correlation analysis. The Kaplan-Meier survival analysis showed that patients with expression of αvβ6 or MMP-9 alone died earlier than those with negative expression and that patients who were both αvβ6 and MMP-9 positive had a shorter overall survival than those with the opposite pattern(both αvβ6 and MMP-9 negative)(P = 0.000). A Cox model indicated that positive expression of αvβ6 and MMP-9, diffuse Lauren type, as well as a senior grade of N stage, M stage, and TNM stage were predictors of a poor prognosis in univariate analysis. Only αvβ6 and MMP-9 retained their significance when adjustments were made for other known prognostic factors in multivariate analysis(RR = 2.632, P = 0.003 and RR = 1.813, P = 0.007).CONCLUSION: The expression of αvβ6 and MMP-9 are closely correlated, and the combinational pattern of αvβ6 and MMP-9 can serve as a more effective prognostic index for gastric cancer patients.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v22.i14.3852</identifier><identifier>PMID: 27076771</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>9;Survival ; Adult ; Aged ; Aged, 80 and over ; Antigens, Neoplasm - analysis ; Biomarkers, Tumor - analysis ; cancer;Integrin ; Chi-Square Distribution ; Female ; Gastric ; Humans ; Immunohistochemistry ; Integrins - analysis ; Kaplan-Meier Estimate ; Male ; Matrix Metalloproteinase 9 - analysis ; metalloproteinase ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Observational Study ; Predictive Value of Tests ; Proportional Hazards Models ; Risk Factors ; Stomach Neoplasms - enzymology ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Stomach Neoplasms - therapy ; Time Factors ; Treatment Outcome ; αvβ6;Prognosis;Matrix</subject><ispartof>World journal of gastroenterology : WJG, 2016-04, Vol.22 (14), p.3852-3859</ispartof><rights>The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2852-1b018c4057bbc5f3223079e5fd2d21eef18f70ff6dea810ccadd68f4d5a3c5ee3</citedby><cites>FETCH-LOGICAL-c2852-1b018c4057bbc5f3223079e5fd2d21eef18f70ff6dea810ccadd68f4d5a3c5ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814749/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814749/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27076771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lian, Pei-Long</creatorcontrib><creatorcontrib>Liu, Zhao</creatorcontrib><creatorcontrib>Yang, Guang-Yun</creatorcontrib><creatorcontrib>Zhao, Rui</creatorcontrib><creatorcontrib>Zhang, Zhao-Yang</creatorcontrib><creatorcontrib>Chen, Yue-Guang</creatorcontrib><creatorcontrib>Zhuang, Zhuo-Nan</creatorcontrib><creatorcontrib>Xu, Ke-Sen</creatorcontrib><title>Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate the expression of integrin αvβ6 and matrix metalloproteinase 9(MMP-9), their association with prognostic factors and to assess their predictive role in gastric cancer patients.METHODS: Immunohistochemistry was used to determine the expressions of integrin αvβ6 and MMP-9 in 126 specimens from patients with primary gastric carcinoma. Associations between immunohistochemical staining and various clinic pathologic variables of tissue specimens were evaluated by the χ2 test and Fisher’s exact test. Expression correlation of αvβ6 and MMP-9 was assessed using bivariate correlation analysis. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 56 mo(ranging from 2 mo to 94 mo).Four different combinations of αvβ6 and MMP-9 levels(that is, both markers positive, both markers negative, αvβ6 positive with MMP-9 negative, and αvβ6 negative with MMP-9 positive) were evaluated for their relative effect on survival. The difference in survival curves was evaluated with a log-rank test. Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis.RESULTS: The expressions of integrin αvβ6 and MMP-9 were investigated in 126 cases, among which 34.92% were positive for αvβ6 expression, and 42.06% for MMP-9 expression. The expression of αvβ6 was associated with Lauren type, differentiation, N stage, and TNM stage(the P values were 0.006, 0.038, 0.016, and 0.002, respectively). While MMP-9 expression was associated with differentiation, T stage, N stage, and TNM stage(the P values were 0.039, 0.014, 0.033, and 0.008, respectively). The positive correlation between αvβ6 and MMP-9 in gastric cancer was confirmed by a correlation analysis. The Kaplan-Meier survival analysis showed that patients with expression of αvβ6 or MMP-9 alone died earlier than those with negative expression and that patients who were both αvβ6 and MMP-9 positive had a shorter overall survival than those with the opposite pattern(both αvβ6 and MMP-9 negative)(P = 0.000). A Cox model indicated that positive expression of αvβ6 and MMP-9, diffuse Lauren type, as well as a senior grade of N stage, M stage, and TNM stage were predictors of a poor prognosis in univariate analysis. Only αvβ6 and MMP-9 retained their significance when adjustments were made for other known prognostic factors in multivariate analysis(RR = 2.632, P = 0.003 and RR = 1.813, P = 0.007).CONCLUSION: The expression of αvβ6 and MMP-9 are closely correlated, and the combinational pattern of αvβ6 and MMP-9 can serve as a more effective prognostic index for gastric cancer patients.</description><subject>9;Survival</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antigens, Neoplasm - analysis</subject><subject>Biomarkers, Tumor - analysis</subject><subject>cancer;Integrin</subject><subject>Chi-Square Distribution</subject><subject>Female</subject><subject>Gastric</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Integrins - analysis</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Matrix Metalloproteinase 9 - analysis</subject><subject>metalloproteinase</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Staging</subject><subject>Observational Study</subject><subject>Predictive Value of Tests</subject><subject>Proportional Hazards Models</subject><subject>Risk Factors</subject><subject>Stomach Neoplasms - enzymology</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - therapy</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>αvβ6;Prognosis;Matrix</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU9rFDEYh4Modq3ePUmOXmbN30nmIkixWih4UfAWspk3sykzyTaZnerHsh-kn8msXRcNhATy-z154UHoNSVrroR-d3czrBfG1oGKNdeSPUErxmjXMC3IU7SihKim40ydoRel3BDCOJfsOTpjiqhWKbpC36_iDEMOET_8Wh7uW2xjjyc75_ADTzDbcUy7nGYI0RbAHXYpZxjtDPguzFtc9nkJix1xBQy21JrDzkYH-SV65u1Y4NXxPEffLj9-vfjcXH_5dHXx4bpxrA7c0A2h2gki1WbjpOeMcaI6kL5nPaMAnmqviPdtD1ZT4pzt-1Z70UvLnQTg5-j9I3e330zQO4hztqPZ5TDZ_NMkG8z_LzFszZAWIzQVSnQV8PYIyOl2D2U2UygOxtFGSPtiqNJUctVyWaPkMepyKiWDP31DiTkIMVWIqUJMFWIOQmrlzb_jnQp_DdQAPzK3KQ63IQ6nTEf0YXWSCC06Kepmf26S_wYyKJuL</recordid><startdate>20160414</startdate><enddate>20160414</enddate><creator>Lian, Pei-Long</creator><creator>Liu, Zhao</creator><creator>Yang, Guang-Yun</creator><creator>Zhao, Rui</creator><creator>Zhang, Zhao-Yang</creator><creator>Chen, Yue-Guang</creator><creator>Zhuang, Zhuo-Nan</creator><creator>Xu, Ke-Sen</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160414</creationdate><title>Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer</title><author>Lian, Pei-Long ; Liu, Zhao ; Yang, Guang-Yun ; Zhao, Rui ; Zhang, Zhao-Yang ; Chen, Yue-Guang ; Zhuang, Zhuo-Nan ; Xu, Ke-Sen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2852-1b018c4057bbc5f3223079e5fd2d21eef18f70ff6dea810ccadd68f4d5a3c5ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>9;Survival</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antigens, Neoplasm - analysis</topic><topic>Biomarkers, Tumor - analysis</topic><topic>cancer;Integrin</topic><topic>Chi-Square Distribution</topic><topic>Female</topic><topic>Gastric</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Integrins - analysis</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Matrix Metalloproteinase 9 - analysis</topic><topic>metalloproteinase</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Staging</topic><topic>Observational Study</topic><topic>Predictive Value of Tests</topic><topic>Proportional Hazards Models</topic><topic>Risk Factors</topic><topic>Stomach Neoplasms - enzymology</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - therapy</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>αvβ6;Prognosis;Matrix</topic><toplevel>online_resources</toplevel><creatorcontrib>Lian, Pei-Long</creatorcontrib><creatorcontrib>Liu, Zhao</creatorcontrib><creatorcontrib>Yang, Guang-Yun</creatorcontrib><creatorcontrib>Zhao, Rui</creatorcontrib><creatorcontrib>Zhang, Zhao-Yang</creatorcontrib><creatorcontrib>Chen, Yue-Guang</creatorcontrib><creatorcontrib>Zhuang, Zhuo-Nan</creatorcontrib><creatorcontrib>Xu, Ke-Sen</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lian, Pei-Long</au><au>Liu, Zhao</au><au>Yang, Guang-Yun</au><au>Zhao, Rui</au><au>Zhang, Zhao-Yang</au><au>Chen, Yue-Guang</au><au>Zhuang, Zhuo-Nan</au><au>Xu, Ke-Sen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2016-04-14</date><risdate>2016</risdate><volume>22</volume><issue>14</issue><spage>3852</spage><epage>3859</epage><pages>3852-3859</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate the expression of integrin αvβ6 and matrix metalloproteinase 9(MMP-9), their association with prognostic factors and to assess their predictive role in gastric cancer patients.METHODS: Immunohistochemistry was used to determine the expressions of integrin αvβ6 and MMP-9 in 126 specimens from patients with primary gastric carcinoma. Associations between immunohistochemical staining and various clinic pathologic variables of tissue specimens were evaluated by the χ2 test and Fisher’s exact test. Expression correlation of αvβ6 and MMP-9 was assessed using bivariate correlation analysis. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 56 mo(ranging from 2 mo to 94 mo).Four different combinations of αvβ6 and MMP-9 levels(that is, both markers positive, both markers negative, αvβ6 positive with MMP-9 negative, and αvβ6 negative with MMP-9 positive) were evaluated for their relative effect on survival. The difference in survival curves was evaluated with a log-rank test. Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis.RESULTS: The expressions of integrin αvβ6 and MMP-9 were investigated in 126 cases, among which 34.92% were positive for αvβ6 expression, and 42.06% for MMP-9 expression. The expression of αvβ6 was associated with Lauren type, differentiation, N stage, and TNM stage(the P values were 0.006, 0.038, 0.016, and 0.002, respectively). While MMP-9 expression was associated with differentiation, T stage, N stage, and TNM stage(the P values were 0.039, 0.014, 0.033, and 0.008, respectively). The positive correlation between αvβ6 and MMP-9 in gastric cancer was confirmed by a correlation analysis. The Kaplan-Meier survival analysis showed that patients with expression of αvβ6 or MMP-9 alone died earlier than those with negative expression and that patients who were both αvβ6 and MMP-9 positive had a shorter overall survival than those with the opposite pattern(both αvβ6 and MMP-9 negative)(P = 0.000). A Cox model indicated that positive expression of αvβ6 and MMP-9, diffuse Lauren type, as well as a senior grade of N stage, M stage, and TNM stage were predictors of a poor prognosis in univariate analysis. Only αvβ6 and MMP-9 retained their significance when adjustments were made for other known prognostic factors in multivariate analysis(RR = 2.632, P = 0.003 and RR = 1.813, P = 0.007).CONCLUSION: The expression of αvβ6 and MMP-9 are closely correlated, and the combinational pattern of αvβ6 and MMP-9 can serve as a more effective prognostic index for gastric cancer patients.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>27076771</pmid><doi>10.3748/wjg.v22.i14.3852</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2016-04, Vol.22 (14), p.3852-3859 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4814749 |
source | MEDLINE; Baishideng "World Journal of" online journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | 9 Survival Adult Aged Aged, 80 and over Antigens, Neoplasm - analysis Biomarkers, Tumor - analysis cancer Integrin Chi-Square Distribution Female Gastric Humans Immunohistochemistry Integrins - analysis Kaplan-Meier Estimate Male Matrix Metalloproteinase 9 - analysis metalloproteinase Middle Aged Multivariate Analysis Neoplasm Staging Observational Study Predictive Value of Tests Proportional Hazards Models Risk Factors Stomach Neoplasms - enzymology Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach Neoplasms - therapy Time Factors Treatment Outcome αvβ6 Prognosis Matrix |
title | Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T11%3A13%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrin%20%CE%B1v%CE%B26%20and%20matrix%20metalloproteinase%209%20correlate%20with%20survival%20in%20gastric%20cancer&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Lian,%20Pei-Long&rft.date=2016-04-14&rft.volume=22&rft.issue=14&rft.spage=3852&rft.epage=3859&rft.pages=3852-3859&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v22.i14.3852&rft_dat=%3Cproquest_pubme%3E1781537635%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781537635&rft_id=info:pmid/27076771&rft_cqvip_id=90888889504849544952484955&rfr_iscdi=true |